01 1Lonza Group
01 1NIACINAMIDE FOR ORAL USE
01 1Switzerland
01 1Active
01 1Complete
GDUFA
DMF Review : Complete
Rev. Date : 2017-01-26
Pay. Date : 2016-09-30
DMF Number : 30711
Submission : 2016-06-13
Status : Active
Type : II
20
Lonza Ag, based in Switzerland, is a pharmaceutical company that stands out with its certifications from FDA and EDQM.
One of their notable products is NIACINAMIDE FOR ORAL USE, with a corresponding US DMF Number 30711.
Remarkably, this DMF maintains an Active status since its submission on June 13, 2016, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of January 26, 2017, and payment made on September 30, 2016, indicating their dedication to facilitating drug approvals, Categorized as Type II
